|
Outcome: Symptoms knowledge (N = 11,254)
|
Model 1
|
Model 2
|
Model 3
|
|---|
| |
PR*
|
95% CrI†
|
PR*
|
95% CrI†
|
PR*
|
95% CrI†
|
|---|
|
Univariate
| | | | | | |
|
Larviciding intervention
|
0.91
|
(0.87-0.95)
|
0.88
|
(0.83-0.92)
|
0.87
|
(0.82-0.92)
|
|
Time since initiation of larviciding (years)
|
-
|
-
|
-
|
-
|
1.03
|
(0.99-1.07)
|
|
Multivariable‡
| | | | | | |
|
Larviciding intervention
|
0.91
|
(0.87-0.95)
|
0.88
|
(0.83-0.92)
|
0.87
|
(0.82-0.92)
|
|
Time since initiation of larviciding (years)
|
-
|
-
|
-
|
-
|
1.01
|
(0.98-1.05)
|
|
Trend for time (AR1§)
|
Yes
|
Yes
|
Yes
|
|
Random effects (TCU)
|
Yes
|
Yes
|
Yes
|
|
Fixed effects at ward level
| |
Yes
|
Yes
|
- Statistically significant results are bolded.
- *PR: Prevalence ratio.
- †CrI: Credible interval.
- §AR1: First-order autoregressive.
- ‡Control variables include: age, gender, dummy for being a follow-up observation, and socio-economic status.
